Replimune stock target raised to $22 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju increased the price target on Replimune Group (NASDAQ:REPL), currently trading at $13.79 with a market cap of $1.06 billion, to $22.00, up from the previous ...
PG&E price target lowered to $18 from $22 at Guggenheim
Guggenheim analyst Shahriar Pourreza lowered the firm’s price target on PG&E to $18 from $22 and keeps a Buy rating on the shares. PG&E ...
Yahoo Finance23d
Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
https://www.tipranks.com/news/the-fly/inmune-bio-price-target-raised-to-23-from-22-at-scotiabank H.C. Wainwright raised the firm’s price target on Monopar ...
Yahoo Finance25d
ZIM Integrated price target lowered to $18 from $22 at Jefferies
https://www.tipranks.com/news/the-fly/boeing-price-target-raised-to-200-from-190-at-jpmorgan Jefferies lowered the firm’s price target on ZIM Integrated (ZIM) to ...